Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes

Type 2 Diabetes Mellitus (T2DM) is associated with a high risk of atherosclerotic cardiovascular (CV) disease. Among the well-known pathophysiologic factors, crucial roles are played by endothelial dysfunction (caused by oxidative stress and inflammation hyperglycemia-linked), increased activity of...

Descripción completa

Detalles Bibliográficos
Autores principales: Patti, Angelo Maria, Rizvi, Ali A, Giglio, Rosaria Vincenza, Stoian, Anca Pantea, Ligi, Daniela, Mannello, Ferdinando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230245/
https://www.ncbi.nlm.nih.gov/pubmed/32225082
http://dx.doi.org/10.3390/jcm9040912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230245/
https://www.ncbi.nlm.nih.gov/pubmed/32225082
http://dx.doi.org/10.3390/jcm9040912

Ejemplares similares